Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in PYPD — PolyPid Ltd.

CIK 1214717 BOSTON, MA
Back to PYPD Full portfolio

Position in PYPD

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$51,800
+$47,222 QoQ
Shares Held
10,197
+2339.5% QoQ
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 33 holders
Holding Since
Jun 2021
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PYPD Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. PYPD ranks #475 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in PYPD

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $51,800 10,197
2023-06-30 $4,578 12,545
2023-03-31 $5,770 12,545
2022-12-31 $8,756 12,545
2022-09-30 $14,677 12,545
2022-06-30 $58,208 12,545
2022-03-31 $68,495 12,545
2021-12-31 $72,008 12,545
2021-09-30 $97,600 12,545
2021-06-30 $101,243 11,181